Les publications de 2019

P186 Grossi, S.; Pineau, S.; Sadot-Lebouvier, S.; Hay, B.; Delaunay, J.; Miailhe, Af.; Bretonniere, C.; Jeddi, F.; Lavergne, R.-A..; Le Pape, P. Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report. Clin. Microbiol. Infect. 2019, 25, 261-263. doi: 10.1016/j.cmi.2018.10.004

P187 Alvarez-Moreno, C.; Lavergne, R.-A.; Hagen, F.; Morio, F.; Meis, J.F.; Le Pape, P. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America. Mycologia 2019, 111, 217-224. doi: 10.1080/00275514.2018.1557796

P188 Le Pape, P.; Ximenes, R. M.; Ariza, B.; Iriarte, J.; Alvarado, J.; Robert, E.; Sierra, C.; Montanez, A., Alvarez-Moreno, C. First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient. Int. J. Infect. Dis. 2019, 81, 85-90. doi: 10.1016/j.ijid.2019.01.043

P189 Lavergne, R.-A.; Morio, F.; Danner-Boucher, I.; Horeau-Langlard, D.; David, V.; Hagen, F.; Meis, JF.; Le Pape, P. One-year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance. J. Antimicrob. Chemother. 2019, 74, 1884-1889. doi: 10.1093/jac/dkz144

P190 Delhaes, L.; Touati, K.; Faure-Cognet, O.; Cornet, M.; Botterel, F.; Dannaoui, E.; Morio, F.; Le Pape, P.; Grenouillet, F.; Favennec, F.; Legal, S.; Nevez, G.; Duhamel.; Borman, A.; Saegeman, V.; Lagrou, K.; Gomez, E.; Carro, ML.; Canton, R.; Campana, S.; Buzina, W.; Chen, S.; Meyer; W.; Roilides, E.; Simitsopoulou, M.; Manso, E.; Cariani, L.; Bifii, A.; Fiscarelli, E.; Ricciotti, G.; Pihet, M.; Bouchara, J.-P. Prevalence, geographic risk factor, and development of standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study "MFIP". J. Cyst. Fibros. 2019, 18, 212-220. doi: 10.1016/j.jcf.2018.10.001

P191 Paret, R.; Le Scornet, T.; Deschanvre, C.; Lecomte, R.; Gaborit, B.; Lavergne, R.-A.; Jeddi, F.; Le Pape, P.; Boutoille, D. Brain abscess to Rasamsonia argillacea in a patient with chronic granulomatous disease. La Lettre de l'Infectiologue • Tome XXXIV - n° 3 - mai-juin 2019.

P192 Morio, F.; Lombardi, L.; Binder, U.; Loge, C.; Robert, E.; Graessle, D.; Bodin, M.; Lass-Flörl, C.; Butler, G.; Le Pape, P. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis. J. Antimicrob. Chemother. 2019, 74, 2230-2238. doi: 10.1093/jac/dkz204

P193 Ceballos-Garzón, A.; Cortes, G.; Morio, F.; Zamora-Cruz, EL.; Linares, MY.; Ariza, BE.; Valderrama, SL.; Garzón, JR.; Alvarez-Moreno, CA.; Le Pape, P.; Parra-Giraldo, CM. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia. BMC Microbiol. 2019, 19, 106. doi: 10.1186/s12866-019-1482-y

P194 Misme-Aucouturier, B.; Touahri, A.; Albassier, M.; Jotereau, F.; Le Pape, P.; Alvarez-Rueda, N. Double positive CD4+CD8+ T cells are part of the adaptive immune response against Candida albicans. Hum. Immunol. 2019, 80, 999-1005. doi: 10.1016/j.humimm.2019.09.008

P195 Le Pape, P.; Alvarez Moreno, C. Candida auris: should we fear the emergence of a highly resistant fungi? La lettre de l’infectiologue. Editorial 2019 Tome XXXVI, 6, 234-235

P196 Flores, O.; Velic, D.; Mabrouk, N.; Bettaieb, A.; Tomasoni, C.; Robert, J.-M.; Paul, C.; Goze, C.; Roussakis, C.; Bodio, E. Rapid synthesis and antiproliferative properties of polyazamacrocycle-based bi- and tetra-gold(I) phosphine dithiocarbamate complexes. ChemBioChem 2019, 20, 2255-2261. doi: 10.1002/cbic.201900227

P197 Dos Santos Dias, A. C.; Couzinet-Mossion, A.; Ruiz, N.; Lakhdar, F.; Etahiri, S.; Bertrand, S.; Ory, L.; Roussakis, C.; Pouchus, Y.-F.; Nazih, H.; Wielgosz-Collin, G. Steroids from Marine-Derived Fungi: Evaluation of Antiproliferative and Antimicrobial Activities of Eburicol. Mar. Drugs 2019, 17, 372. doi:10.3390/md17060372

P198 Iradyan, M.; Iradyan, N.; Hulin, P.; Hambardzumyan, A.; Gyulkhandanyan, A.; Alves de Sousa, R.; Hessani, A.; Roussakis, C.; Bollot, G.; Bauvais, C.; Sakanyan, V. Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death. Cancers, 2019, 11, 1094. doi: 10.3390/cancers11081094

P199 Roque Marques, K. M.; do Desterro, M. R.; de Arruda, S. M.; de-Araújo Neto, L. N.; de Lima, M. D. C. A.; de Almeida, S. M. V.; Silva, E. C. D. D.; Aquino, T. M.; Júnior, E. F. D. S.; Júnior, J. X. D.; Silva, M. M.; de A. Dantas, M. D.; C. Santos, J. C.; Figueiredo, I.M.; Bazin, M.-A.; Marchand, P.; da Silva, T. G.; Mendonça Junior, F. J. B. 5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by apoptosis and DNA intercalation. Curr. Top. Med. Chem. 2019, 19, 1075-1091. doi: 10.2174/1568026619666190621120304

P200 Pereira, P. S.; de Lima, M. D. C. A.; Neto, P. P. M.; de Morais Oliveira-Tintino, C. D.; Tintino, S. R.; de Alencar Menezes, I. R.; Ferreira de Oliveira, J.; Marchand, P.; Melo Coutinho, H. D.; do Desterro Rodrigues, M.; da Silva, T. G. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains. Bioorg. Med. Chem. 2019, 27, 3797-3804. doi: 10.1016/j.bmc.2019.07.006

P201 Elia, J.; Carbonnelle, D.; Logé, C.; Ory, L.; Huvelin, J.-M.; Tannoury, M.; Diab-Assaf, M.; Petit, K.; Nazih, H. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters. Lipids Health Dis. 2019, 18, 168. doi: 10.1186/s12944-019-1103-7

P202 Nascimento da Cruz, A. C.; Brondani, D .J.; I´talo de Santana, T.; Oliveira da Silva, L.; da Oliveira Borba, E. F.; de Faria, A. R.; Ferreira Cavalcanti de Albuquerque, J.; Piessard, S.; Matos Ximenes, R.; Baratte, B.; Bach, S.; Ruchaud, S.; Bezerra Mendonça Junior, F. J.; Bazin, M.-A.; Montenegro Rabello, M.; Hernandes, M. Z.; Marchand, P.; Gonçalves da Silva, T. Biological evaluation of arylsemicarbazone derivatives as potential anticancer agents. Pharmaceuticals 2019, 12, 169. doi:10.3390/ph12040169

P203 de Oliveira Pedrosa Rolim, M.; Rodrigues de Almeida, A.; Galdino da Rocha Pitta, M.; Barreto de Melo Rêgo, M. J.; Quintans-Júnior, L. J.; de Souza Siqueira Quintans, J.; Heimfarth, L.; Scotti, L.; Scotti, M. T.; Marques Duarte da Cruz, R.; Nóbrega de Almeida, R.; da Silva, T. G.; de Oliveira, J. A.; de Campos, M. L.; Marchand, P.; Mendonça Junior, F. J. B. Synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent. Int. Immunopharmacol. 2019, 76, 105856. doi:10.1016/j.intimp.2019.105856

P204 Barreto Mota, F. V.; Saraiva de Araújo Neta, M.; de Souza Franco, E.; Gomes Alves Bastos, I. V.; Cardoso Correia da Araújo, L.; Cabral da Silva, S.; Bezerra de Oliveira, T.; Souza, E.. K.; Moraes de Almeida, V.; Matos Ximenes, R.; de Sousa Maia, M. B.; Mendonça Junior, F. J. B.; Marchand, P.; de Faria, A. R.; da Silva, T. G. Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives. Med. Chem. Commun. 2019, 10, 1916-1925. doi: 10.1039/c9md00276f
 

P205 Aldholmi, M.; Marchand, P.; Ourliac-Garnier, I.; Le Pape, P.; Ganesan, A. A decade of antifungal leads from natural products: 2010-2019. Pharmaceuticals 2019, 12, 182; doi:10.3390/ph12040182.